- Home
- ARVN vs PFL Comparison
ARVN vs PFL Comparison
Compare ARVN & PFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARVN
- PFL
- Stock Information
- Founded
- ARVN 2015
- PFL 2003
- Country
- ARVN United States
- PFL United States
- Employees
- ARVN N/A
- PFL N/A
- Industry
- ARVN Biotechnology: Pharmaceutical Preparations
- PFL Finance Companies
- Sector
- ARVN Health Care
- PFL Finance
- Exchange
- ARVN Nasdaq
- PFL Nasdaq
- Market Cap
- ARVN 456.2M
- PFL 374.5M
- IPO Year
- ARVN 2018
- PFL N/A
- Fundamental
- Price
- ARVN $7.95
- PFL $8.33
- Analyst Decision
- ARVN Buy
- PFL
- Analyst Count
- ARVN 21
- PFL 0
- Target Price
- ARVN $20.53
- PFL N/A
- AVG Volume (30 Days)
- ARVN 1.8M
- PFL 113.7K
- Earning Date
- ARVN 08-05-2025
- PFL 01-01-0001
- Dividend Yield
- ARVN N/A
- PFL 11.53%
- EPS Growth
- ARVN N/A
- PFL N/A
- EPS
- ARVN N/A
- PFL N/A
- Revenue
- ARVN $426,900,000.00
- PFL N/A
- Revenue This Year
- ARVN $7.57
- PFL N/A
- Revenue Next Year
- ARVN N/A
- PFL N/A
- P/E Ratio
- ARVN N/A
- PFL N/A
- Revenue Growth
- ARVN 498.74
- PFL N/A
- 52 Week Low
- ARVN $5.90
- PFL $6.98
- 52 Week High
- ARVN $29.96
- PFL $8.62
- Technical
- Relative Strength Index (RSI)
- ARVN 51.19
- PFL 56.47
- Support Level
- ARVN $7.41
- PFL $8.30
- Resistance Level
- ARVN $8.05
- PFL $8.35
- Average True Range (ATR)
- ARVN 0.37
- PFL 0.05
- MACD
- ARVN -0.02
- PFL 0.01
- Stochastic Oscillator
- ARVN 50.00
- PFL 88.46
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
About PFL PIMCO Income Strategy Fund Shares of Beneficial Interest
PIMCO Income Strategy Fund is a United States-based closed-end management investment company. The fund's investment objective is to seek high current income, consistent with the preservation of capital. It seeks to achieve its objectives by investing in a diversified portfolio of floating and fixed-rate debt instruments.